This is a non-laser intranasal light therapy device. The basic specifications include an optimally-engineered diode (LED) emitting photons within the visible red spectrum(633 nm) wavelength powered by a calculated dosage of energy to irradiate the capillary-rich nasal cavity.

Our intranasal devices combine solid state technology along with intranasal diodes built from transparent high impact polycarbonate to ensure quality and durability, turning this into a lifetime investment.

The Vielight 633 Red releases light with a wavelength of 633 nm in the visible red spectrum, powered by a managed dosage of energy controlled by circuitry. Low level light therapy has been researched by NASA for several years and has demonstrated the ability to alter, and improve, cellular function.

In particular, it is believed that photobiomodulation functions by improving mitochondrial energy production by stimulating the complex IV enzyme, cytochrome c oxidase (CCO), increasing adenosine-5?-triphosphate (ATP) synthesis, and releasing mild reactive oxygen species (ROS) as redox signaling agents.